vancomycin has been researched along with minocycline in 160 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.88) | 18.7374 |
| 1990's | 18 (11.25) | 18.2507 |
| 2000's | 49 (30.63) | 29.6817 |
| 2010's | 81 (50.63) | 24.3611 |
| 2020's | 9 (5.63) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, DT; Katz, L; Plattner, JJ | 1 |
| Clark, NC; Donlan, RM; Dumas, N; Jensen, B; Kohlerschmidt, D; Limberger, RJ; McDougal, LK; Musser, KA; Patel, JB; Shin, DH; Thompson, J; Weigel, LM; Zhu, W | 1 |
| Fiett, J; Gniadkowski, M; Grzesiowski, P; Hryniewicz, W; Izdebski, R; Sadowy, E | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Chaiban, G; Dvorak, T; Hachem, R; Hanna, H; Jiang, Y; Raad, I; Reitzel, R; Sherertz, R | 1 |
| Calvo, J; Martínez-Martínez, L; Salas, C | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bowker, KE; Macgowan, AP; Noel, AR | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
| Appelbaum, PC; Beachel, L; Caspers, P; Clark, C; Dewasse, B; Ednie, LM; Gaucher, B; Kosowska-Shick, K; Lin, G; McGhee, P; Mert, G; Shapiro, S; Smith, K | 1 |
| Bowker, KE; Caspers, P; Gaucher, B; MacGowan, AP | 1 |
| Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Steenbergen, J; Tanaka, SK; Villano, S | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Agostinho, ÍRC; Araújo, AR; Campos, MAS; de Alcântara Oliveira, FA; de Carvalho Sousa, B; de Oliveira Castelo Branco, RR; Dos Santos Soares, MJ; Gonzalez, AGM; Lopes, AP; Pinheiro, REE; Rocha, JA | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
| Hida, S; Matsuda, T; Takeuchi, H; Yoshida, O; Yu, MD | 1 |
| Ema, H; Hoshino, M; Imagawa, S; Itoh, M; Komatsu, N; Kurata, H; Suzuki, T; Tsunoda, J; Tsunoda, S; Yoshida, M | 1 |
| Matsumoto, K; Nagatake, T | 1 |
| Kunihiro, M; Nakamura, I; Unoki, T | 1 |
| Waddell, AD; Walsh, WT; Wisseman, CL | 1 |
| Hoppes, WL; Lerner, PI | 1 |
| Yokota, K | 1 |
| Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A | 1 |
| Coe, CJ; Freeman, CD; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
| Nicolau, DP; Nightingale, CH; Onyeji, CO; Tessier, PR | 1 |
| Fujita, K; Kato, H; Nagamachi, Y; Okubo, T; Suzuki, T | 1 |
| Freeman, CD; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
| Deguchi, T; Ito, Y; Kanematsu, M; Kawada, Y; Komeda, H; Okano, M; Saitoh, A; Takahashi, Y; Tokuyama, H; Yamada, S | 1 |
| Bodey, GP; Darouiche, R; Hachem, R; Raad, I; Sacilowski, M | 1 |
| Honma, K; Okuda, K; Tawara, Y | 1 |
| Beck, T; Darouiche, RO; Isiklar, ZU; Landon, GC | 1 |
| Johnson, DM; Jones, RN | 1 |
| Handwerger, S; Mildvan, D; Shonekan, D | 1 |
| Fluit, A; Heinz, HP; Jones, ME; Schmitz, FJ; Verhoef, J | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Ishikawa, S; Koyano, T; Morishita, Y; Noda, D; Ooki, S; Shimizu, H; Takahashi, T | 1 |
| Murray, BE; Nannini, EC; Pai, SR; Singh, KV | 1 |
| Hijioka, S; Nakata, R; Nishimura, T; Sugita, K; Yoshinami, Y | 1 |
| Bouza, E; Cercenado, E; Cercenado, S; Gómez, JA | 1 |
| LaPlante, KL; Rybak, MJ | 1 |
| Calhoun, JH; Lazzarini, L; Li, F; Stevens, CM; Yin, LY | 1 |
| Babinchak, T; Dartois, N; Ellis-Grosse, EJ; Loh, E; Rose, G | 1 |
| Campos, ME; Curcio, D; Ellis-Grosse, E; Embil, JM; Loh, E; Penn, RL; Rose, G; Sacchidanand, S | 1 |
| Breedt, J; Dartois, N; Ellis-Grosse, EJ; Gardovskis, J; Gioud-Paquet, M; Loh, E; Maritz, FJ; Ross, DP; Teras, J; Vaasna, T | 1 |
| Boger, MS; Collins, CA; Mason, L; Raad, II; Sherertz, RJ | 1 |
| Fujiwara, H; Hamaguchi, H; Kubo, T; Taniguchi, D; Tsuji, Y | 1 |
| Manfredi, R | 1 |
| Chambers, HF; Hegde, SS | 1 |
| Bradford, PA; Jones, CH; Petersen, PJ | 1 |
| Graninger, W; Hirschl, AM; Kratzer, C; Presterl, E; Rabitsch, W | 1 |
| Eder, M; Graninger, W; Hirschl, AM; Lassnigg, A; Presterl, E; Reichmann, S | 1 |
| Jenkins, I | 1 |
| Anstead, GM; Lewis, JS; Quinones-Nazario, G | 1 |
| Loffler, CA; Macdougall, C | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Teng, LJ | 1 |
| Kollef, MH; Micek, ST; Skrupky, LP | 1 |
| Hanaki, H; Ikeda-Dantsuji, Y; Nagasawa, Z; Nagayama, A; Oshiro, T | 1 |
| Mangino, JE; Schafer, JJ | 1 |
| Babinchak, T; Beuran, M; Bochan, M; Cooper, CA; Dartois, N; Dimov, R; Dukart, G; Ellis-Grosse, EJ; Fichev, G; Florescu, I; Gandjini, H; Razbadauskas, A | 1 |
| Decker, CF; Johnson, MD | 1 |
| Cooper, A; Dartois, N; Dukart, G; Gardovskis, J; Jouve, S; Kupcs, U; Pupelis, G; Teras, J; Vaasna, T | 1 |
| Poppens, PT; Rose, WE | 1 |
| Adochitei, A; Duez, JM; Neuwirth, C; Péchinot, A; Siebor, E; Sixt, N | 1 |
| Boone, TB; Darouiche, RO; Mansouri, MD | 1 |
| Fleury, B; Gjinovci, A; Huggler, E; Lew, DP; Tangomo-Bento, M; Vaudaux, P | 1 |
| Graninger, W; Hajdu, S; Hirschl, AM; Lassnigg, A; Presterl, E | 1 |
| Graninger, W; Hajdu, S; Hirschl, AM; Holinka, J; Lassnigg, AM; Presterl, E | 1 |
| Ellermann-Eriksen, S; Kristensen, L; Rathe, M; Schumacher, H; Thomsen, MK | 1 |
| Dufort, EM; Eberson, CP; Harwell, JI; Vinson, AE; Willis, MD | 1 |
| Hennenfent, J; Lambert, BL; McBride, MV; Rodvold, KA; Schiff, G; Schumock, GT; Trese, AM; Tverdek, F; Yang, Y | 1 |
| Graninger, W; Hajdu, S; Hirschl, AM; Holinka, J; Presterl, E; Reichmann, S | 1 |
| Ku, TS; Lee, SA; Palanisamy, SK | 1 |
| Antoniadou, A; Armaganidis, A; Dimopoulou, I; Kopterides, P; Papadomichelakis, E; Papageorgiou, C; Tsangaris, I | 1 |
| Dhabuwala, C; Sheth, S; Zamzow, B | 1 |
| Levy, F; Peterson, SM; Reynolds, SA; Sarubbi, FA; Shams, W; Walker, ES | 1 |
| Derendorf, H; Estes, KS | 1 |
| Dryden, M; Eckmann, C | 1 |
| Bai, N; Cai, Y; Liang, B; Liu, Y; Wang, R | 1 |
| Diagre, D; Hussain, Z; John, MA; Milburn, S; Stuart, JI; Wilson, B | 1 |
| Cauda, R; Esposito, S; Garau, J; Gould, IM; Gudiol, F; Mazzei, T | 1 |
| Aradhya, S; Chang, CM; Chuang, YC; Cooper, A; Dartois, N; Jouve, S; Nagari, B; Pai, V | 1 |
| Chaffins, ML; Kerr, HA; Lopiccolo, MC; Workman, BJ | 1 |
| Chang, SC; Chen, YC; Kao, TM; Wang, JT; Weng, CM | 1 |
| Chen, CC; Chiang, SR; Chuang, YC; Ko, WC; Tang, HJ; Yu, WL | 1 |
| Ariza, J; Cabellos, C; Cabo, J; Euba, G; Garrigós, C; Murillo, O; Tubau, F; Verdaguer, R | 1 |
| Cleveland, KO; Gelfand, MS; Twilla, JD; Usery, JB | 1 |
| Babinchak, T; McGovern, P; Quintana, A | 1 |
| Sancak, B | 1 |
| Badiou, C; Couet, W; Lina, G; Pantrangi, M; Pichereau, S; Rose, WE; Shukla, SK | 1 |
| Baban, TA; El-Herte, RI; Kanj, SS | 1 |
| Cesur, S; Demiröz, AP; Irmak, H; Karakoç, E; Kınıklı, S; Pelitli, TS | 1 |
| Dowzicky, MJ; Namdari, H; Tan, TY | 1 |
| Chen, CM; Chen, WY; Chen, YH; Chen, YS; Cheng, YJ; Chiang, PC; Chuang, YC; Hsu, GJ; Hsueh, PR; Huang, CH; Jang, TN; Ko, WC; Kung, HC; Lee, CM; Lee, MH; Liao, CH; Lin, HC; Liu, CE; Liu, JW; Liu, YC; Lu, CT; Lu, PL; Pan, SC; Shi, ZY; Sun, W; Tsao, SM; Wang, LS; Yang, JL; Yu, KW | 2 |
| Aybar, Y; Besirli, K; Engin, E; Karabulut, E; Mert, A; Mete, B; Ozaras, R; Ozturk, R; Salihoglu, T; Tabak, F; Tahan, G; Yilmaz, MH | 1 |
| Betriu, C; Canut, A; Gascón, AR; Isla, A | 1 |
| Billi, F; Francis, KP; Miller, LS; Niska, JA; Pribaz, JR; Ramos, RI; Shahbazian, JH | 1 |
| d'Azevedo, PA; da Silva Paim, TG; de Oliveira, CF; Reiter, KC; Sambrano, GE; Villa, B | 1 |
| Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN | 1 |
| Bossé, D; Cantin, AM; Lemire, C; Ménard, F; Ruel, J; Valiquette, L | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Ballerini, V; Bantar, C; Herrera, M; Limansky, A; Mobilia, L; Posse, G | 1 |
| Beaume, M; Francois, P; Harrison, PF; Hernandez, D; Howden, BP; Schrenzel, J; Seemann, T; Stinear, TP | 1 |
| Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
| Fortier, LC; Garneau, JR; Valiquette, L | 1 |
| Castaing, N; Cooper, A; Dartois, N; Dukart, G; Embil, JM; Lauf, L; Maroko, R; Mitha, I; Ozsvár, Z; Regöly-Mérei, J; Sabol, MB; Yan, J | 1 |
| Abduljaleel, SA; Atshan, SS; Awang Hamat, R; Ghaznavi-Rad, E; Jeevajothi Nathan, J; Karunanidhi, A; Lung, LT; Mateg Ali, A; Nor Shamsudin, M; Pei Pei, C; Sekawi, Z | 1 |
| Muscedere, J | 1 |
| Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Tsaganos, T; Tzepi, IM | 1 |
| Arias, CA; Carvajal, LP; Díaz, L; Munita, JM; Panesso, D; Reyes, J; Rincón, S | 1 |
| Chhibber, S; Chopra, S; Harjai, K | 1 |
| Beamer, G; Kim, HB; Sun, X; Tzipori, S; Wang, Y; Zhang, Q | 1 |
| Coato, P; Cojutti, P; Pea, F; Rigoli, R; Sartor, A; Scarparo, C | 1 |
| Belyaev, O; Chromik, AM; Deleites, C; Herzog, T; Uhl, W | 1 |
| Bassis, CM; Schumacher, CA; Seekatz, AM; Theriot, CM; Young, VB | 1 |
| Mandrekar, JN; Patel, R; Schmidt-Malan, SM; Steckelberg, JM; Vergidis, P | 1 |
| Behl, P; Chander, J; Gupta, V; Sahoo, T; Singla, N | 1 |
| Baos, E; Candel, FJ; Nieto, M; Picazo, JJ | 1 |
| Budimir, A | 1 |
| Bartolomeu, AR; Brito, CI; Camargo, CH; Cunha, ML; Oliveira, A; Pereira, VC; Pinheiro, L | 1 |
| Aslan, H; Yapar, N | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Di Conza, J; Di Gregorio, S; Fernandez, S; Herrera, M; Mollerach, M; Posse, G | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Chu, CM; Lee, CW; Lee, SC; Liu, YC; See, LC; Shih, TC | 1 |
| Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
| Ertugrul, BM; Gunay, N; Ozturk, B; Sakarya, S | 1 |
| Hamada, Y; Monogue, ML; Nicolau, DP; Thabit, AK | 1 |
| Bernhardt, PV; Capon, RJ; Khalil, Z; Salim, AA; Shang, Z | 1 |
| Ashbaugh, AG; Bernthal, NM; Hegde, V; Loftin, AH; Miller, LS; Niska, JA; Segura, T; Stavrakis, AI; Zhu, S | 1 |
| Dezsenyi, B; Fried, K; Gergely Szabo, B; Kadar, B; Kamotsay, K; Kunovszki, P; Nikolova, R; Prinz, G; Szidonia Lenart, K | 1 |
| Benea, SN; Hristea, A; Jipa, RE; Manea, E; Rodríguez-Baño, J; Sojo-Dorado, J | 1 |
| Cheng, JW; Kong, F; Kudinha, T; Liao, JW; Xiao, M; Xu, YC; Yang, QW; Yu, SY; Zhou, ML | 1 |
| Bishop, EJ; Botha, J; Kelley, PG; Marshall, C; Metcalfe, J; Tiruvoipati, R | 1 |
| Helon, P; Juda, M; Malm, A | 1 |
| Chakraborty, S; Cheng, X; Galla, S; Joe, B; Mathew, AV; Mell, B; Vijay-Kumar, M; Yeo, J; Zhang, H | 1 |
| Afriat, D; Bara Passot, C; Barbaud, A; Bensaid, B; Beylot-Barry, M; Caux, F; Descamps, V; Duvert-Lehembre, S; Garel, B; Grootenboer-Mignot, S; Ingen-Housz-Oro, S; Jeudy, G; Lebrun-Vignes, B; Prost-Squarcioni, C; Soria, A; Tétart, F; Valnet-Rabier, MB | 1 |
| Akinci, E; Baran, I; Bodur, H; Mumcuoglu, I; Sertcelik, A | 1 |
| Broomhead, M; Eriksson, E; Grolman, J; Lipsitz, S; Mooney, D; Nuutila, K; Onderdonk, A; Yang, L | 1 |
| Bostrom, MP; Carli, AV; Driscoll, DA; Levack, AE; Miller, AO; Turajane, K; Wellman, DS; Yang, X | 1 |
| Habib, A; Qadir, A | 1 |
| Fujii, R; Imai, Y; Muranaka, T; Nishiyama, N; Tanaka, M; Tomita, S; Uchitani, K | 1 |
| Bleick, C; Daffinee, KE; LaPlante, KL; Piehl, EC | 1 |
| Hsueh, PR; Lee, YL | 1 |
19 review(s) available for vancomycin and minocycline
| Article | Year |
|---|---|
New directions in antibacterial research.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Molecular Sequence Data; Molecular Structure | 1996 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Conformation; Tetracyclines | 2016 |
[MRSA septicemia caused by an infected pacemaker lead: a case report with a review of Japanese literatures].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cardiopulmonary Bypass; Dibekacin; Drug Therapy, Combination; Female; Humans; Methicillin Resistance; Middle Aged; Minocycline; Pacemaker, Artificial; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2000 |
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin | 2007 |
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Treatment of infections caused by resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2007 |
Optimizing therapy for MRSA pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcus aureus; Tigecycline; Vancomycin | 2007 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Skin Diseases; Soft Tissue Infections; Tigecycline; Vancomycin | 2010 |
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
Topics: Anti-Bacterial Agents; Communicable Diseases; Drug Resistance, Bacterial; Enterococcus; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2011 |
Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Pneumonia, Bacterial; Staphylococcal Infections; Teicoplanin; Tigecycline; Treatment Outcome; Vancomycin | 2011 |
Silicone granulomas after soft-tissue augmentation of the buttocks: a case report and review of management.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Buttocks; Female; Granuloma, Foreign-Body; Humans; Minocycline; Silicones; Tetracycline; Vancomycin | 2011 |
[Staphylococcus aureus and antibiotic resistance].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin | 2011 |
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin | 2012 |
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Genes, Bacterial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Minocycline; Staphylococcal Infections; Tigecycline; Vancomycin | 2014 |
MRSA in Croatia: prevalence and management.
Topics: Animals; Anti-Bacterial Agents; Carrier State; Cattle; Croatia; Daptomycin; Humans; Linezolid; Livestock; Methicillin-Resistant Staphylococcus aureus; Minocycline; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Swine; Teicoplanin; Tigecycline; Vancomycin; Zoonoses | 2016 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefiderocol; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2023 |
7 trial(s) available for vancomycin and minocycline
| Article | Year |
|---|---|
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Bacteria; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Random Allocation; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2005 |
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
Topics: Anti-Bacterial Agents; Aztreonam; Double-Blind Method; Drug Therapy, Combination; Female; Gram-Positive Cocci; Humans; India; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Nausea; North America; Skin Diseases, Bacterial; South America; Streptococcus pyogenes; Tigecycline; Treatment Outcome; Vancomycin; Vomiting | 2005 |
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Aztreonam; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2005 |
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspective.
Topics: Anti-Bacterial Agents; Aztreonam; Double-Blind Method; Drug Therapy, Combination; Female; Humans; International Agencies; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Skin Diseases, Bacterial; Tigecycline; Treatment Outcome; Vancomycin | 2008 |
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Double-Blind Method; Drug Therapy, Combination; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Nausea; Skin Diseases, Bacterial; Taiwan; Tigecycline; Vancomycin; Vomiting | 2011 |
Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetic Foot; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Minocycline; Nausea; Osteomyelitis; Tigecycline; Treatment Outcome; Vancomycin; Vomiting; Young Adult | 2014 |
134 other study(ies) available for vancomycin and minocycline
| Article | Year |
|---|---|
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Topics: Acetamides; Aminoglycosides; Biofilms; Catheters, Indwelling; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Fluoroquinolones; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Morganella morganii; Oxazolidinones; Penicillins; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Catheterization; Vancomycin; Vancomycin Resistance | 2007 |
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
Topics: Bacterial Proteins; Cell Lineage; DNA Transposable Elements; Genetic Variation; Poland; Streptococcus pneumoniae; Tetracycline; Tetracycline Resistance | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Daptomycin; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline | 2007 |
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
Topics: Actinomycetales; Anti-Bacterial Agents; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model.
Topics: Anti-Bacterial Agents; Area Under Curve; Colony Count, Microbial; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Vancomycin | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Folic Acid Antagonists; Microbial Sensitivity Tests; Phthalazines; Staphylococcus aureus; Staphylococcus epidermidis; Tetrahydrofolate Dehydrogenase | 2009 |
In vitro activities of three new dihydrofolate reductase inhibitors against clinical isolates of gram-positive bacteria.
Topics: Folic Acid Antagonists; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phthalazines; Staphylococcus aureus; Streptococcus | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2021 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
[Urinary tract infection caused by Corynebacterium sp.--a case report and an experimental study].
Topics: Administration, Oral; Animals; Corynebacterium Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Minocycline; Piperacillin; Rats; Rectal Fistula; Urinary Bladder Calculi; Urinary Bladder Fistula; Urinary Tract Infections; Vancomycin | 1992 |
[Staphylococcus aureus sepsis in patients with hematological malignancies: increase in MRSA sepsis].
Topics: Adult; Aged; Aged, 80 and over; Chloramphenicol; Female; Humans; Leukemia; Male; Methicillin Resistance; Middle Aged; Minocycline; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1990 |
[A case of septicemia caused by Alcaligenes dentrificans subspecies xylosoxidans and a review of the literature].
Topics: Aged; Alcaligenes; Aortic Valve Insufficiency; Cross Infection; Drug Therapy, Combination; Humans; Hypertension; Male; Minocycline; Sepsis; Vancomycin | 1986 |
In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bacteriological Techniques; Chick Embryo; Chloramphenicol; Culture Techniques; Dimethyl Sulfoxide; Doxycycline; Erythromycin; Gentamicins; Kanamycin; Minocycline; Neomycin; Oxacillin; Penicillin G; Rickettsia Infections; Rickettsia prowazekii; Rifampin; Streptomycin; Tetracycline; Ultrafiltration; Vancomycin | 1974 |
Nonenterococcal group-D streptococcal endocarditis caused by Streptococcus bovis.
Topics: Adult; Aged; Ampicillin; Cephalosporins; Child; Chloramphenicol; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Gastrointestinal Diseases; Gentamicins; Humans; Kanamycin; Lincomycin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxacillin; Penicillin G; Streptococcal Infections; Streptococcus; Streptomycin; Tetracycline; Urologic Diseases; Vancomycin | 1974 |
[Nosocomial infections].
Topics: Cross Infection; Disinfection; Granulocyte Colony-Stimulating Factor; Humans; Methicillin Resistance; Minocycline; Premedication; Pseudomonas Infections; Staphylococcal Infections; Vancomycin | 1993 |
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin | 1995 |
Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.
Topics: Animals; Aortic Valve; Endocarditis, Bacterial; Female; Microbial Sensitivity Tests; Minocycline; Oxacillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Vancomycin | 1994 |
Caution in the use of commercial serum.
Topics: Animals; Blood; Blood Preservation; Cephalosporins; Mice; Microbial Sensitivity Tests; Minocycline; Quality Control; Rabbits; Reproducibility of Results; Vancomycin | 1994 |
[MRSA infections in surgery].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Minocycline; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Pharmacokinetics of minocycline and vancomycin in rabbits.
Topics: Animals; Female; Half-Life; Minocycline; Rabbits; Vancomycin | 1993 |
[A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Humans; Immunocompromised Host; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Urologic Diseases; Vancomycin | 1993 |
Antibiotics and prevention of microbial colonization of catheters.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Candida; Catheters, Indwelling; Clindamycin; Drug Synergism; Drug Therapy, Combination; Equipment Contamination; Minocycline; Novobiocin; Rifampin; Staphylococcus; Vancomycin | 1995 |
Detection of methicillin-resistant staphylococcus aureus in human saliva and on denture surfaces.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biofilms; Dental Care for Aged; Dentures; Drug Resistance, Microbial; Equipment Contamination; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Minocycline; Saliva; Staphylococcus aureus; Staphylococcus epidermidis; Tetracycline; Vancomycin | 1994 |
Efficacy of antibiotics alone for orthopaedic device related infections.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Minocycline; Prosthesis-Related Infections; Rabbits; Random Allocation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1996 |
Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
Topics: Anti-Bacterial Agents; Chloramphenicol; Erythromycin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Minocycline; Molecular Structure; Teicoplanin; Tetracyclines; Vancomycin | 1996 |
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Quinolones; Teicoplanin; Tetracyclines; Vancomycin; Virginiamycin | 1997 |
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Germany; Hospitals; Humans; Longitudinal Studies; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Activity of tigecycline (GAR-936), a novel glycylcycline, against Enterococci in the mouse peritonitis model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Enterococcus faecium; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Minocycline; Peritonitis; Tetracyclines; Tigecycline; Vancomycin | 2003 |
[Survey of susceptibility of methicillin-resistant Staphylococcus aureus to antimicrobial agents in Hokusetsu General Hospital].
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; Drug Resistance, Bacterial; Hospitals, General; Japan; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Teicoplanin; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2002 |
In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides.
Topics: Anti-Bacterial Agents; Enterococcus; Microbial Sensitivity Tests; Minocycline; Staphylococcus; Tigecycline; Vancomycin; Vancomycin Resistance | 2003 |
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin | 2004 |
Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
Topics: Animals; Bone and Bones; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Minocycline; Osteomyelitis; Rabbits; Radiography; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin | 2005 |
Comparative in vitro efficacies of various catheter lock solutions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Candida albicans; Catheterization; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Edetic Acid; Ethanol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Pharmaceutical Preparations; Pseudomonas aeruginosa; Rifampin; Solutions; Staphylococcus aureus; Staphylococcus epidermidis; Taurine; Thiadiazines; Time Factors; Vancomycin | 2006 |
Use of antibiotic bead chains for septic arthritis of bilateral knee joints.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Drug Delivery Systems; Female; Humans; Knee Joint; Microspheres; Minocycline; Staphylococcal Infections; Vancomycin | 2006 |
In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton broth.
Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Gram-Negative Aerobic Rods and Cocci; Gram-Positive Cocci; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Tigecycline; Vancomycin | 2007 |
In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Coagulase; Daptomycin; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Hematologic Neoplasms; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin | 2007 |
Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Prosthesis-Related Infections; Streptococcal Infections; Tigecycline; Treatment Outcome; Vancomycin; Viridans Streptococci | 2007 |
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Minocycline; Oxazolidinones; Tigecycline; Treatment Outcome; Vancomycin | 2007 |
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin | 2007 |
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Topics: Acetamides; Anti-Infective Agents; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcus aureus; Streptococcaceae; Taiwan; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2008 |
The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin.
Topics: Anti-Bacterial Agents; Bacteriolysis; Drug Resistance, Multiple, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Minocycline; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Iraq; Male; Middle Aged; Minocycline; Osteomyelitis; Tigecycline; Vancomycin | 2008 |
Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacteremia; Biofilms; Colony Count, Microbial; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Rifampin; Staphylococcal Infections; Tigecycline; Vancomycin | 2009 |
In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin | 2008 |
Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses.
Topics: Animals; Anti-Bacterial Agents; Drug Implants; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus; Escherichia coli; Escherichia coli Infections; Male; Methicillin-Resistant Staphylococcus aureus; Minocycline; Penile Prosthesis; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2009 |
Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Foreign Bodies; Methicillin-Resistant Staphylococcus aureus; Minocycline; Rats; Staphylococcal Infections; Tigecycline; Vancomycin | 2009 |
Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Daptomycin; Dose-Response Relationship, Drug; Fosfomycin; Humans; Minocycline; Skin; Staphylococcus aureus; Tigecycline; Vancomycin | 2009 |
Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Ceftriaxone; Daptomycin; Microbial Sensitivity Tests; Minocycline; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2009 |
Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Daptomycin; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Polymerase Chain Reaction; Reproducibility of Results; Tigecycline; Vancomycin; Vancomycin Resistance | 2010 |
Drug rash, eosinophilia, and systemic symptoms syndrome: Two pediatric cases demonstrating the range of severity in presentation--A case of vancomycin-induced drug hypersensitivity mimicking toxic shock syndrome and a milder case induced by minocycline.
Topics: Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Drug Hypersensitivity; Eosinophilia; Exanthema; Humans; Male; Minocycline; Severity of Illness Index; Shock, Septic; Syndrome; Vancomycin | 2010 |
Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Clinical Protocols; Daptomycin; Formularies, Hospital as Topic; Guidelines as Topic; Health Care Surveys; Hospitals; Humans; Infection Control; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Organizational Policy; Oxazolidinones; Patient Isolation; Pharmacy Service, Hospital; Staphylococcal Infections; Surveys and Questionnaires; Tigecycline; Vancomycin | 2010 |
Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Cefamandole; Daptomycin; Fosfomycin; Minocycline; Staphylococcus; Tigecycline; Vancomycin | 2010 |
Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals.
Topics: Anti-Infective Agents; Azithromycin; Biofilms; Candida albicans; Drug Interactions; Humans; Inhibitory Concentration 50; Minocycline; Tigecycline; Vancomycin | 2010 |
Failure of tigecycline to treat severe Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Critical Care; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Treatment Failure; Vancomycin | 2010 |
Infection rates of rifampin/gentamicin-coated Titan Coloplast penile implants. Comparison with Inhibizone-impregnated AMS penile implants.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Coated Materials, Biocompatible; Drug Therapy, Combination; Gentamicins; Humans; Male; Middle Aged; Minocycline; Penile Prosthesis; Prosthesis-Related Infections; Retrospective Studies; Rifampin; United States; Vancomycin | 2011 |
Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; Daptomycin; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Minocycline; Oxazolidinones; Tigecycline; Vancomycin | 2010 |
Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; DNA, Ribosomal; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Micrococcal Nuclease; Minocycline; Oxacillin; Oxazolidinones; Penicillin-Binding Proteins; Polymerase Chain Reaction; Staphylococcus; Tigecycline; Vancomycin | 2011 |
In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Blood; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Taiwan; Tigecycline; Vancomycin | 2011 |
In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Topics: Acetamides; Anti-Infective Agents; Biofilms; Drug Synergism; Drug Therapy, Combination; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Stem Cells; Tigecycline; Vancomycin | 2011 |
Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Foreign Bodies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Models, Animal; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tigecycline; Time Factors; Treatment Outcome; Vancomycin | 2011 |
Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2011 |
Clarification to the systematic review and meta-analysis involving tigecycline.
Topics: Anti-Bacterial Agents; Communicable Diseases; Humans; Minocycline; Vancomycin | 2011 |
Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cell Culture Techniques; Clindamycin; Community-Acquired Infections; Enzyme-Linked Immunosorbent Assay; Exotoxins; Gene Expression Regulation, Bacterial; Humans; Leukocidins; Leukocytes, Mononuclear; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Models, Biological; Oxazolidinones; Real-Time Polymerase Chain Reaction; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virulence Factors | 2012 |
[Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin | 2011 |
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
Topics: Acetamides; Acinetobacter baumannii; Carbapenems; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Humans; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Skin; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2012 |
Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline; Vancomycin | 2012 |
Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline; Vancomycin | 2012 |
Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Blood; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Culture Techniques; Disease Models, Animal; Female; Heparin; Humans; Microscopy, Electron, Scanning; Minocycline; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Time Factors; Vancomycin | 2012 |
Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.
Topics: Acetamides; Anti-Bacterial Agents; Belgium; Daptomycin; Ireland; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Spain; Staphylococcal Infections; Tigecycline; United Kingdom; Vancomycin | 2012 |
Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Daptomycin; Drug Administration Schedule; Humans; Injections, Intravenous; Knee Prosthesis; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Minocycline; Models, Animal; Molecular Imaging; Prosthesis-Related Infections; Staphylococcal Infections; Tigecycline; Vancomycin | 2012 |
Enhancement of antistaphylococcal activities of six antimicrobials against sasG-negative methicillin-susceptible Staphylococcus aureus: an in vitro biofilm model.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Biofilms; Brazil; Catheter-Related Infections; Humans; Membrane Proteins; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin | 2012 |
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2012 |
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
Topics: Administration, Oral; Adult; Anaphylaxis; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cystic Fibrosis; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Metronidazole; Minocycline; Severity of Illness Index; Tigecycline; Vancomycin | 2013 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Comparative time-kill study of doxycycline, tigecycline, cefazolin and vancomycin against several clones of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Argentina; Cefazolin; Doxycycline; Genotype; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin | 2013 |
Analysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposure.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Protein Biosynthesis; RNA, Bacterial; RNA, Messenger; RNA, Small Untranslated; Sequence Analysis, RNA; Tigecycline; Transcription, Genetic; Vancomycin | 2013 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin | 2014 |
Genotypically different clones of Staphylococcus aureus are diverse in the antimicrobial susceptibility patterns and biofilm formations.
Topics: Acetamides; Anti-Infective Agents; Biofilms; Daptomycin; Genetic Variation; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Minocycline; Oxazolidinones; Staphylococcal Infections; Tigecycline; Vancomycin | 2013 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
Comparative efficacy of tigecycline VERSUS vancomycin in an experimental model of soft tissue infection by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Drug Administration Schedule; Exotoxins; Immunocompromised Host; Injections, Intraperitoneal; Kaplan-Meier Estimate; Leukocidins; Lipid Peroxidation; Male; Methicillin-Resistant Staphylococcus aureus; Minocycline; Random Allocation; Rats, Wistar; Soft Tissue Infections; Staphylococcal Infections; Thigh; Tigecycline; Vancomycin; Virulence | 2015 |
Antibiotic susceptibility of ica-positive and ica-negative MRSA in different phases of biofilm growth.
Topics: Anti-Bacterial Agents; Biofilms; Clindamycin; DNA, Bacterial; Enzyme-Linked Immunosorbent Assay; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcal Infections; Vancomycin | 2015 |
Beneficial effect of oral tigecycline treatment on Clostridium difficile infection in gnotobiotic piglets.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Fluoroquinolones; Germ-Free Life; Humans; Interleukin-8; Microbiota; Minocycline; Pyrimidinones; Swine; Tigecycline; Vancomycin | 2014 |
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.
Topics: Acetamides; Anti-Bacterial Agents; Blood; Daptomycin; Health Surveys; Humans; Italy; Linezolid; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2015 |
[Clostridium difficile in visceral surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Germany; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Metronidazole; Middle Aged; Minocycline; Patient Readmission; Retrospective Studies; Survival Rate; Tigecycline; Vancomycin; Young Adult | 2015 |
Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clostridioides difficile; Colon; Enterocolitis, Pseudomembranous; Feces; Female; Male; Mice; Mice, Inbred C57BL; Minocycline; Tigecycline; Vancomycin | 2015 |
Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Humans; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Tigecycline; Vancomycin | 2015 |
Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents.
Topics: Anti-Infective Agents; Daptomycin; Humans; Linezolid; Minocycline; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virginiamycin | 2015 |
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2015 |
Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood Culture; Brazil; Daptomycin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, Teaching; Humans; Linezolid; Minocycline; Mutation; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin; Virginiamycin | 2016 |
[Comparison of tigecycline and vancomycin activities in an in vitro biofilm model generated with methicillin-resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Biofilms; Catheter-Related Infections; Coloring Agents; Congo Red; Disk Diffusion Antimicrobial Tests; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxacillin; Staphylococcal Infections; Tigecycline; Vancomycin | 2015 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
In vitro selection of Staphylococcus aureus mutants resistant to tigecycline with intermediate susceptibility to vancomycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Mutation; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin | 2016 |
Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multilocus Sequence Typing; Taiwan; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.
Topics: Anti-Bacterial Agents; Biofilms; Coagulase; Daptomycin; Microbial Viability; Minocycline; Models, Biological; Staphylococcus; Tigecycline; Vancomycin | 2016 |
Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus; Tetracyclines; Thienamycins; Tigecycline; Vancomycin | 2016 |
Fungal Biotransformation of Tetracycline Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biotransformation; Chlortetracycline; Crystallography, X-Ray; Doxycycline; Drug Resistance, Fungal; Fermentation; Fungi; Genome, Fungal; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Minocycline; Mollusca; Oxygen; Oxytetracycline; Tetracycline; Vancomycin | 2016 |
In Vivo Efficacy of a "Smart" Antimicrobial Implant Coating.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Mice; Minocycline; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Tigecycline; Vancomycin | 2016 |
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Minocycline; Recurrence; Retrospective Studies; Sepsis; Tigecycline; Treatment Outcome; Vancomycin | 2016 |
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Minocycline; Polymerase Chain Reaction; Retrognathia; Tigecycline; Vancomycin | 2018 |
High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; China; Clostridioides difficile; Clostridium Infections; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fidaxomicin; Fluoroquinolones; Genes, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Multilocus Sequence Typing; Ribotyping; Tigecycline; Vancomycin | 2018 |
The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome; Vancomycin | 2018 |
ANTI-ADHESIVE AND ANTI-BIOFILM ACTIVITIES IN VITRO OF LINEZOLID, VANCOMYCIN, TIGECYCLINE AND DAPTOMYCIN AGAINST STAPHYLOCOCCUS HAEMOLYTICUS.
Topics: Adhesiveness; Anti-Bacterial Agents; Biofilms; Catheters; Daptomycin; Drug Resistance, Multiple, Bacterial; Linezolid; Microbial Sensitivity Tests; Minocycline; Staphylococcus haemolyticus; Tigecycline; Vancomycin | 2016 |
Disparate effects of antibiotics on hypertension.
Topics: Animals; Anti-Bacterial Agents; Blood Pressure; Gastrointestinal Microbiome; Hypertension; Minocycline; Neomycin; Rats, Inbred Dahl; Rats, Inbred SHR; Sodium Chloride, Dietary; Species Specificity; Vancomycin | 2018 |
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Databases, Factual; Diagnosis, Differential; Doxycycline; Drug Monitoring; Enoxaparin; Female; France; Humans; Linear IgA Bullous Dermatosis; Male; Middle Aged; Minocycline; Pharmacovigilance; Prevalence; Retrospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Vancomycin; Young Adult | 2019 |
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Minocycline; Sulbactam; Vancomycin | 2020 |
Immediate Treatment of Burn Wounds with High Concentrations of Topical Antibiotics in an Alginate Hydrogel Using a Platform Wound Device.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Alginates; Animals; Anti-Bacterial Agents; Burns; Female; Gentamicins; Hydrogels; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Swine; Vancomycin; Wound Healing; Wound Infection | 2020 |
Identifying alternative antibiotics that elute from calcium sulfate beads for treatment of orthopedic infections.
Topics: Amikacin; Anti-Bacterial Agents; Calcium Sulfate; Cefazolin; Meropenem; Minocycline; Tobramycin; Vancomycin | 2022 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
[A Case of Thrombocytopenia Following Minocycline Administration].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Minocycline; Piperacillin, Tazobactam Drug Combination; Thrombocytopenia; Vancomycin | 2023 |
Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus epidermidis; Vancomycin | 2023 |